Christopher Guttman-McCabe - Feb 28, 2024 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Chief Reg & Comm Officer
Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Feb 28, 2024
Transactions value $
$0
Form type
4
Date filed
3/1/2024, 09:27 PM
Previous filing
Nov 17, 2023
Next filing
May 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +60K $0.00 60K Feb 28, 2024 Common Stock 60K $37.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 8,000 of the option shares vest and become exercisable on May 22, 2024; 32,000 additional option shares vest and become exercisable on May 22, 2025; and the remaining 20,000 unvested option shares vest and become exercisable on May 22, 2026.